The impact of antiviral therapy on hepatocellular carcinoma epidemiology
The development of nucleos(t)ide analogs and direct antiviral agents has revolutionized the management of chronic infection with HBV and HCV, respectively. These regimens allow to expand treatment to virtually all infected, including those with poor hepatic reserve and those with severe comorbiditie...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2018-01-01
|
| Col·lecció: | Hepatic Oncology |
| Matèries: | |
| Accés en línia: | https://www.futuremedicine.com/doi/10.2217/hep-2017-0024 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|